Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
Crossref DOI link: https://doi.org/10.1038/bjc.2016.66
Published Online: 2016-03-24
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fry, Simon A
Robertson, Claire E
Swann, Ruth
Dwek, Miriam V
Text and Data Mining valid from 2016-03-24
Article History
Revised: 14 July 2015
Accepted: 13 January 2016
First Online: 24 March 2016
Competing interests
: The authors declare no conflict of interest.